On Monday, Mira Pharmaceuticals Inc (NASDAQ: MIRA) was -2.63% drop from the session before settling in for the closing price of $1.90. A 52-week range for MIRA has been $0.51 – $6.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
When this article was written, the company’s average yearly earnings per share was at 21.88%. With a float of $9.96 million, this company’s outstanding shares have now reached $14.78 million.
Let’s look at the performance matrix of the company that is accounted for 3 employees. In terms of profitability, gross margin is 0.0%, operating margin of 0.0%, and the pretax margin is 0.0%.
Mira Pharmaceuticals Inc (MIRA) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Mira Pharmaceuticals Inc stocks. The insider ownership of Mira Pharmaceuticals Inc is 32.64%, while institutional ownership is 4.97%. The most recent insider transaction that took place on Sep 04 ’24, was worth 18,000. Before that another transaction happened on Aug 28 ’24, when Company’s 10% Owner sold 200,000 for $1.96, making the entire transaction worth $392,000. This insider now owns 2,540,270 shares in total.
Mira Pharmaceuticals Inc (MIRA) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.17 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 21.88% per share during the next fiscal year.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Trading Performance Indicators
You can see what Mira Pharmaceuticals Inc (MIRA) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 3.68.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.84, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.56 in one year’s time.
Technical Analysis of Mira Pharmaceuticals Inc (MIRA)
Mira Pharmaceuticals Inc (NASDAQ: MIRA) saw its 5-day average volume 6.36 million, a positive change from its year-to-date volume of 2.28 million. As of the previous 9 days, the stock’s Stochastic %D was 61.84%. Additionally, its Average True Range was 0.26.
During the past 100 days, Mira Pharmaceuticals Inc’s (MIRA) raw stochastic average was set at 29.78%, which indicates a significant decrease from 53.90% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 150.28% in the past 14 days, which was lower than the 354.29% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.3708, while its 200-day Moving Average is $1.1967. Nevertheless, the first resistance level for the watch stands at $2.1100 in the near term. At $2.3699, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.5299. If the price goes on to break the first support level at $1.6901, it is likely to go to the next support level at $1.5301. The third support level lies at $1.2702 if the price breaches the second support level.
Mira Pharmaceuticals Inc (NASDAQ: MIRA) Key Stats
There are 14,781K outstanding shares of the company, which has a market capitalization of 27.34 million. As of now, sales total 0 K while income totals -11,980 K. Its latest quarter income was 0 K while its last quarter net income were -1,690 K.
